# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-015345
Filing Date
2022-04-25
Accepted
2022-04-25 09:01:50
Documents
3
Period of Report
2022-05-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | hrtx-def14a_20220524.htm | DEF 14A | 2409144
2 | GRAPHIC | g2xlixepzqvs000001.jpg | GRAPHIC | 561571
3 | GRAPHIC | g2xlixepzqvs000002.jpg | GRAPHIC | 370700
| Complete submission text file | 0001564590-22-015345.txt |  | 3694481

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 22847493
SIC: 2834 Pharmaceutical Preparations